Figure 2a and 2b.

Hazard ratio for death among HCV-seropositive candidates associated with a) kidney transplantation compared to remaining on the waiting list, b) kidney transplantation with a HCV-seropositive kidney compared to the strategy of remaining on the waitlist and/or accepting a HCV-negative kidney*

* Models were time updated for transplantation and included age, gender, race, diabetes, cardiovascular disease, severe liver disease, insurance, income, panel reactive antibody, dialysis vintage, prior kidney transplant, body mass index, dialysis modality, year of waitlisting interacted with time, hemoglobin, platelets, and albumin.